Q1 2025 Management View CEO Dan O'Brien began by emphasizing the company's focus on its NanoChem division (NCS), which ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...